Organization: Health Canada
Year: 2024
Month: July
Request Number: A-2023-001331
Request Summary: Advise whether the Mesalazine Abbreviated New Drug Submission (ANDS) has received either: a Screening Acceptance Letter; a Notice of Deficiency (NOD); a Notice of Non-Compliance (NON); a NOD-Withdrawal (NOD-W); or a NON-Withdrawal (NON-W).
Disposition: Disclosed in part
Number of pages: 27